Reaction
Retinal Toxicity reporting signals
As of the last recalculation, Retinal Toxicity appears in 1,005 FAERS reports alongside 30 co-occurring drug terms. The strongest observed disproportionality signal is HYDROXYCHLOROQUINE (PRR 90.0).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Hydroxychloroquine | 246 | 90.0 | 90.3 |
| Efavirenz | 42 | 81.4 | 81.7 |
| Cefuroxime | 40 | 75.4 | 75.7 |
| Quinine | 23 | 56.8 | 57.0 |
| Abacavir Sulfate | 20 | 43.4 | 43.4 |
| Lamivudine Oral | 50 | 43.0 | 43.1 |
| Tenofovir Disoproxil Fumarate Tablets | 17 | 41.5 | 41.5 |
| Ritonavir 100 Mg | 29 | 41.4 | 41.4 |
| Vigabatrin | 27 | 39.4 | 39.5 |
| Lamivudine | 52 | 36.7 | 36.8 |
| Ganciclovir Sodium | 16 | 31.8 | 31.8 |
| Anastrozole Tablets | 27 | 26.8 | 26.8 |
| Hydroxychloroquine Sulfate | 105 | 26.5 | 26.6 |
| Ritonavir | 34 | 24.9 | 24.9 |
| Melphalan Hydrochloride | 29 | 24.6 | 24.7 |
| Melphalan | 26 | 24.3 | 24.3 |
| Zidovudine | 12 | 18.8 | 18.8 |
| Leflunomide | 81 | 17.3 | 17.4 |
| Raltegravir | 13 | 16.5 | 16.5 |
| Ganciclovir | 8 | 16.3 | 16.3 |
| Entecavir | 9 | 16.1 | 16.1 |
| Atazanavir | 11 | 16.0 | 16.0 |
| Anastrozole | 27 | 15.6 | 15.6 |
| Tofacitinib Citrate | 9 | 14.3 | 14.3 |
| Tocilizumab | 72 | 14.0 | 14.0 |
| Gemcitabine | 23 | 12.4 | 12.4 |
| Tenofovir Disoproxil Fumarate | 17 | 10.8 | 10.8 |
| Gemcitabine Hydrochloride | 27 | 10.8 | 10.8 |
| Brinzolamide | 4 | 9.6 | 9.6 |
| Encorafenib | 4 | 8.4 | 8.4 |